MODERN ASPECTS IN PATHOGENESIS AND TREATMENT TRIGEMINAL NEURALGIA

The investigating of the clinical presentation, state of the cellular and humoral immunity, process of a fibrillation and fibrinolysis by the patients with trigeminal neuralgia is carried out in this article. The result of this research is the establishment of the development of the secondary immunodeficiency and emergence of signs of chronic DIC-syndrome by the patients with trigeminal neuralgia. Use of the bioregulators (cortexin, epytalaminum) in combination with Finlepsin promoted the normalization of fibrillation process and specific immunity that increased the efficiency of treatment of patients with TGN (lengthening of the period of remission, decrease in intensity and frequency of pain-ful attack, etc.).